COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 268: Articles 2671-2680  | Next

Serological markers and Post COVID-19 Condition (PCC): A rapid review of the evidence
Collins, E., Philippe, E., Gravel, C., Hawken, S., Langlois, M.-A., Little, J.
10.1101/2023.10.30.23297455 — Posted: 2023-10-30
Predictive factors of non-pharmacological measures to prevent SARS-CoV-2 contagion: A cross-sectional study in a large adult Spanish sample from PSY-COVID study
Mateo-Canedo, C., Sanabria-Mazo, J. P., Navarro, J. B., Cigarroa, I., Alvarez, M., Armayones, M., Martinez-Blanquet, L. J., Zapata-Lamana, R., Crespo Puig, N., Korniyenko, M., Sanz, A.
10.1101/2023.10.30.23297748 — Posted: 2023-10-30
Trade unions and mental health during an employment crisis. Evidence from the UK before and during the COVID-19 pandemic.
Kromydas, T., Demou, E., Leyland, A. H., Katikireddi, S. V., Wels, J.
10.1101/2023.10.30.23297780 — Posted: 2023-10-30
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineages dissemination in Brazil in 2023
Arantes, I., Gomes, M. F. C., Ito, K., Sarafim, S., Miyajima, F., Khouri, R., Graf, T., Siqueira, M., Bello, G., Resende, P., Naveca, F.
10.1101/2023.10.30.23297466 — Posted: 2023-10-30
Epitope mapping of SARS-CoV 2 RBDs by hydroxyl radical protein footprinting reveals the importance of including negative antibody controls.
Larsen, D. N., Kaczmarek, J. Z., Palarasah, Y., Graversen, J. H., Hojrup, P.
10.1101/2023.10.27.564378 — Posted: 2023-10-30
Colloidal aggregation confounds cell-based Covid-19 antiviral screens
Glenn, I. S., Hall, L. N., Khalid, M. M., Ott, M., Shoichet, B. K.
10.1101/2023.10.27.564435 — Posted: 2023-10-30
Deciphering the code of viral-host adaptation through maximum entropy models
Di Gioacchino, A., Greenbaum, B. D., Monasson, R., Cocco, S.
10.1101/2023.10.28.564530 — Posted: 2023-10-30
Inhalation Delivered RNA Aptamer for Therapeutics against SARS-CoV2
Song, M., Zhou, J., Herrara, A., Bains, P., Rossi, J.
10.1101/2023.10.28.564096 — Posted: 2023-10-30
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection
Drelich, A. K., Rayavara, K., Hsu, J., Saenkham-Huntsinger, P., Judy, B. M., Tat, V., Ksiazek, T. G., Peng, B.-H., Tseng, C.-T. K.
10.1101/2023.10.30.564680 — Posted: 2023-10-30
NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19
Lee, M. J., de los Rios Kobara, I., Barnard, T. R., Vales Torres, X., Tobin, N. H., Ferbas, K. G., Rimoin, A. W. J., Yang, O. O., Aldrovandi, G. M., Wilk, A. J., Fulcher, J., Blish, C. A.
10.1101/2023.10.27.564440 — Posted: 2023-10-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).